258 related articles for article (PubMed ID: 20514639)
1. [Perspectives on the amyloid cascade hypothesis of Alzheimer's disease].
Simón AM; Frechilla D; del Río J
Rev Neurol; 2010 Jun; 50(11):667-75. PubMed ID: 20514639
[TBL] [Abstract][Full Text] [Related]
2. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
Hardy J; Selkoe DJ
Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
[TBL] [Abstract][Full Text] [Related]
3. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
4. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
[TBL] [Abstract][Full Text] [Related]
5. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
7. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
[TBL] [Abstract][Full Text] [Related]
8. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
Wirths O; Multhaup G; Bayer TA
J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta, tau, and dementia.
Takashima A
J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
[TBL] [Abstract][Full Text] [Related]
10. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
11. The amyloid cascade hypothesis.
Korczyn AD
Alzheimers Dement; 2008 May; 4(3):176-8. PubMed ID: 18631966
[TBL] [Abstract][Full Text] [Related]
12. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease. A new take on tau.
Marx J
Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
[No Abstract] [Full Text] [Related]
14. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
Gouras GK; Almeida CG; Takahashi RH
Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Carter CJ
Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
[TBL] [Abstract][Full Text] [Related]
17. [Alzheimer's disease and the proteins].
Morishima-Kawashima M; Saido TC; Ihara Y
Tanpakushitsu Kakusan Koso; 2001 Aug; 46(11 Suppl):1798-804. PubMed ID: 11579581
[No Abstract] [Full Text] [Related]
18. Pathogenesis of Alzheimer's disease and dementia.
Bugiani O
Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
[TBL] [Abstract][Full Text] [Related]
19. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
